Biogen Inc. (NASDAQ: BIIB) has steadily declined since peaking at $468.55 in 2021, as shares are trading down 70.64% from ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...

31.01.2025 / 12:10 CET/CEST The issuer is solely responsible for the content of this announcement. Marinomed Biotech AG: Changes to the Management Board CFO Pascal Schmidt is resigning at the end ...

CFO Pascal Schmidt is resigning at the end of January 2025 Gabriele Ram, former Wienerberger AG, takes over the management of the finance department on an interim basis Restructuring proceedings ...

EQS-News: Marinomed Biotech AG / Key word(s): Personnel Marinomed Biotech AG: Changes to the Management Board 31.01.2025 / 12:10 CET/CEST The issuer is solely responsible for the content of this ...

Andrew Pierce is the senior vice president of discovery and development at a company that claims to be “first end-to-end AI biotech,” but he admits he doesn’t know the first thing about ...

The science is still ultimately going to drive this.” Biotech science and the companies bringing it to the medical market in Seattle lifted the region into the Top 10 of U.S. biotech “clusters ...

Curie.Bio, the biotech accelerator and investment firm started by Alexis Borisy and Zach Weinberg, has raised another $340 million to invest in startups. Borisy and Weinberg’s firm was created ...

Bookshop, a site that lets independent, bricks-and-mortar bookshops sell their books online, is launching an app that will allow the sales of e-books, too. By Alexandra Alter When Andy Hunter ...

His latest book is “House of Bone and Rain.” The Japanese author Uketsu, according to his biography, “only ever appears online, wearing a mask and speaking through a voice changer.” ...

China Medical System (CHSYF) entered into a Collaboration Agreement with Hunan Mabgeek Biotechnology and its subsidiary for Class 1 innovative drug anti-IL-4Ralpha humanized monoclonal antibody ...